INS and metabolic syndrome: Lim et al. [43] also reported similar observations where GA improved dyslipidemia via the selective induction of tissue lipoprotein lipase (a key regulator of lipoprotein metabolism) expression and inhibited the development of insulin sensitivity associated with tissue steatosis.